ApplyBlast uses AI to match you with the right jobs, tailor your resume and cover letter, and apply automatically so you can land your dream job faster.
© All Rights Reserved. ApplyBlast.com
ApplyBlast uses AI to match you with the right jobs, tailor your resume and cover letter, and apply automatically so you can land your dream job faster.
© All Rights Reserved. ApplyBlast.com
Deciphex
Diagnexia, a subsidiary of Deciphex, specializes in AI diagnostic solutions for pathology, aiming to accelerate drug development and improve patient outcomes through innovative software and digital pathology services. They offer a remote opportunity for board-certified general pathologists to work with whole-slide imaging technology. The company values trust and flexibility, providing training and a collaborative environment.
Deciphex is a medtech company specializing in AI-powered digital pathology, building platforms that empower a global network of pathologists to deliver faster and more accurate diagnostics. Its solutions serve both clinical settings — such as reducing NHS pathology wait times — and the pharmaceutical industry, accelerating preclinical drug development for top pharma companies. The company recently secured a €15M venture debt facility with Claret Capital Partners to accelerate its growth.
Headquarters
San Francisco, CA
Company Size
201-500 employees
Founded
2018
Industry
Technology
Glassdoor Rating
4.2 / 5
Sarah Johnson
Chief Executive Officer
Michael Chen
Chief Technology Officer
Emily Williams
VP of Engineering
David Rodriguez
VP of Product
Jessica Thompson
Chief Financial Officer
Andrew Park
VP of Sales
View leadership team, funding history,
and employee contacts for Deciphex.
Deciphex didn’t post a salary, so this is our estimate from similar listings.
28% below the average for this role